ALLMedicine™ Prostatitis Center
Research & Reviews 1,641 results
https://doi.org/10.1016/j.urology.2021.01.018
Urology Zhang K, Liu Y et. al.
Jan 22nd, 2021 - To validate the efficacy and safety of Ningmitai capsule (NMT) in the patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a multicenter, randomized, double-blind, placebo-controlled trial in 120 men with CP/CPPS ...
https://doi.org/10.1002/pros.24101
The Prostate; Aydogdu O, Gocun PU et. al.
Jan 19th, 2021 - The aim of the present study was to investigate the effects of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function and pathophysiology. To create a model for CPPS, rats were intraprostatically injected with zymosan or sa...
https://doi.org/10.1007/s00345-020-03577-2 10.1016/j.eururo.2008.03.073 10.1016/S0022-5347(05)66541-X 10.1111/j.1525-1497.2001.01223.x 10.1001/jama.2010.1913 10.1186/s12894-017-0223-5 10.1016/S0090-4295(99)00358-1 10.1016/j.eururo.2009.05.046 10.1016/S0090-4295(02)02383-X 10.1016/S0022-5347(05)68562-X 10.1016/S0090-4295(97)00238-0 10.1097/01.ju.0000054983.45096.16 10.1007/s00345-013-1075-6 10.1016/j.urology.2019.02.030 10.1097/01.ju.0000101487.83730.80 10.1016/j.eururo.2007.11.026 10.1111/j.1464-410X.2006.06098.x 10.1016/j.juro.2017.01.035 10.1007/s00345-018-2409-1 10.1002/(SICI)1097-0045(19990215)38:3<208::AID-PROS5>3.0.CO;2-4 10.1111/bju.14362 10.1016/j.eururo.2013.04.035 10.1056/NEJMoa0803240 10.1111/j.1464-410X.2008.08087.x
World Journal of Urology; Zhang K, Guo RQ et. al.
Jan 16th, 2021 - To perform a placebo-controlled trial to evaluate the efficacy and safety of Serenoa repens extract (SRE) for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a double-blind, randomized, placebo-controlled,...
https://doi.org/10.1007/s00345-020-03580-7 10.1016/j.juro.2007.08.046 10.4081/aiua.2018.4.227 10.1016/j.eururo.2006.07.016 10.5534/wjmh.2017.35.2.120 10.1136/gutjnl-2011-300971 10.1186/s12876-017-0605-x 10.4103/1008-682X.131064 10.1016/j.ijantimicag.2008.11.012 10.4111/icu.2017.58.6.460 10.1016/S1043-6618(03)00003-3 10.1016/j.eururo.2004.12.025 10.1159/000474438 10.1038/nature12820 10.1038/s41391-018-0041-1 10.1097/00004836-200603000-00020 10.3945/jn.114.197723 10.1177/2050640617736478 10.3748/wjg.v21.i21.6698 10.1159/000019784
World Journal of Urology; Cai T, Gallelli L et. al.
Jan 14th, 2021 - To evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 (L. casei DG®) in both prevention of symptomatic recurrences and improvement of quality of life in patients with chronic bacterial prostatitis (CBP). Patients with CBP attending a sin...
https://doi.org/10.1080/0092623X.2020.1871142
Journal of Sex & Marital Therapy; Stamatiou K, Samara E et. al.
Jan 7th, 2021 - Chronic prostatitis (CP) is a common health condition in men. Albeight obvious, a relationship between microbial induced prostatic inflammation and sexual function has not been as thoroughly investigated. Aiming to investigate possible association...
Drugs 339 results see all →
Clinicaltrials.gov 2,045 results
https://doi.org/10.1016/j.urology.2021.01.018
Urology Zhang K, Liu Y et. al.
Jan 22nd, 2021 - To validate the efficacy and safety of Ningmitai capsule (NMT) in the patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a multicenter, randomized, double-blind, placebo-controlled trial in 120 men with CP/CPPS ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd98465c-60d1-42d7-a24b-49889fc123e5
Jan 19th, 2021 - Levofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4). • Pneumonia: Nosocomial ( 1.1) ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=766e1318-dbaf-402f-9d67-cdf8a9ebb9f5
Jan 19th, 2021 - Ciprofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Inf...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d395c25-2bb1-4d7a-a6fd-f7d89a4601e3
Jan 19th, 2021 - Levofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4). • Pneumonia: Nosocomial ( 1.1) ...
https://doi.org/10.1002/pros.24101
The Prostate; Aydogdu O, Gocun PU et. al.
Jan 19th, 2021 - The aim of the present study was to investigate the effects of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function and pathophysiology. To create a model for CPPS, rats were intraprostatically injected with zymosan or sa...
News 55 results
https://www.medscape.com/viewarticle/862520
May 1st, 2016 - The incidence of true urinary tract infection (UTI) in adult males younger than 50 years is low (approximately 5-8 per year per 10,000), with adult females being 30 times more likely than males to develop a UTI. The incidence of UTI in males appro...
https://reference.medscape.com/viewarticle/862520
May 1st, 2016 - The incidence of true urinary tract infection (UTI) in adult males younger than 50 years is low (approximately 5-8 per year per 10,000), with adult females being 30 times more likely than males to develop a UTI. The incidence of UTI in males appro...
https://www.medscape.com/viewarticle/856273
Dec 27th, 2015 - What Is Causing the Chest Pain? A 67-year-old man presents with severe chest pain radiating down both his arms. He has been in good health until the past 2 months, when he was diagnosed with and treated for gastroesophageal reflux and, more recent...
https://www.mdedge.com/internalmedicine/article/103425/infectious-diseases/old-drug-new-treatment-chronic-prostatitis
Bruce Jancin
Oct 9th, 2015 - SAN DIEGO – Oral fosfomycin, a drug used for more than 4 decades to treat urinary tract infections in women, has gained a new life as a promising treatment for chronic prostatitis. In the largest patient series reported to date, a 6-week course of.
https://www.medscape.com/viewarticle/851302
Sep 21st, 2015 - SAN DIEGO — High cure rates can be achieved with fosfomycin in patients with chronic prostatitis — many of whom are resistant to the current first-line treatment of fluoroquinolones — according to results from a new study. "For us, it's an alterna...